Surprisingly, the additional inhibition of FGF signaling also mitigated the inhibition of osteogenic differentiation with dorsomorphin in both groups (OM +/− BMP-2) of pBMSCs and in pASCs with BMP-2 supplementation. This evidence concerns the gene BMP2 and ocular melanoma.